Detalhe da pesquisa
1.
Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre.
Int J Clin Pract
; 75(12): e14955, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34610193
2.
Comparison of Early and Late Onset Psoriasis (EOP and LOP) Regarding Systemic Inflammatory Comorbidities: LOP is a More Rapid Subtype of Psoriasis.
Dermatol Pract Concept
; 12(3): e2022144, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36159130